Table 1 Characterization of the study population and samples
Characteristics | Atopic dermatitis | Healthy controls |
|---|---|---|
Subjects analysed, N | 10 | 5 |
Age, mean (range), years | 47 (24–62) | 48 (27–63) |
Female:male ratio | 7:3 | 3:2 |
SCORAD | ||
 Mean (range) | 31 (20–68) | NA |
 Moderate: Severe | 8:2 | NA |
 Filaggrin Mutation: Wt: Unknown | 4:1:5 | Unknown |
 HECSI, mean (range) | 10 (4–16) | NA |
Treatment | ||
 No | 2 | 5 |
 Steroid | 5 | 0 |
 Systemic | 4 | 0 |
Nizoral | ||
 Occasionally: likely after study participation | 1:1 | 0 |
Co-morbidities | ||
 Asthma | 5 | 0 |
 Hay fever | 5 | 0 |
 CD | 5 | 1 |
 FA | 1 | 0 |
Skin site successfully sampled, Nonlesional:lesional ratio | ||
 Nasal | 8:1 | 5 |
 Periorbital | 2:3 | 5 |
 Perioral | 4:4 | 5 |
 Neck | 2:3 | 5 |
 Upper inner arms | 0:2 | 3 |
 Antecubital fossae | 1:3 | 5 |
 Volar forearms | 0:2 | 3 |
 Dorsum of hands | 0:1 | 3 |
 Palmar hands | 3:2 | 3 |
 Between fingers | 0:5 | 5 |
 Popliteal flexures | 1:1 | 4 |
 Dorsum of feet | 0:2 | 5 |
 Arches of feet | 0:1 | 5 |
 Between toes | 6:2 | 5 |